6818 Austin Center Blvd #200

CTSI is now on Facebook!

Currently Enrolling

• eXtreme Lateral Total Disc Replacement
• Facet Replacement
• CoFlex
• Bone Marrow Aspirate Concentrate
• Lateral Interbody Fusion
• Mesoblast Stem Cell Fusion

If you are a new or established patient, please complete our patient satisfaction survey:

We are currently enrolling patients for this U.S. Food and Drug Administration (FDA) Clinical Trial. 

Double click for more information on the AFRS study

The Paradigm Spine - Coflex® is a device designed to treat spinal stenosis, a condition that can cause pain, weakness, numbness or other sensations in the lower back, buttocks and legs.
 

We are currently enrolling patients in this FDA-approved Clinical Trial.

Double click for more information on Coflex study

Richard Wupperman, M.D. , is the principal investigator for this IRB-approved clinical outcomes trial.  The eXtreme Lateral Interbody Fusion (XLIF) uses an FDA-approved device developed by Nuvasive, Inc. for minimally invasive spinal fusion.  It can be used to treat a variety of spinal disorders caused by degenerative disc disease (DDD) in adults, including spondylosis, spondylolisthesis, and scoliosis.

Dr. Wupperman is currently enrolling patients in this study.

In the XLIF, the surgeon performs the discectomy and fusion through a tube placed through the patient's side.  Patients must be between 18 and 89 years of age to participate.

For more information, please contact our study coordinator, Amy, via email at studyinfo@pqrinc.com.

Bone Marrow Aspirate Concentrate (BMAC) from SpineSmith is being compared to the current gold-standard in spinal fusions, Bone Morphogenetic Protein (BMP).

We are currently enrolling patients for this U.S. Food and Drug Administration (FDA) Randomized Clinical Trial.  Please contact our office for more information.